- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Natalizumab
Total 125 results
-
BiogenCompletedRelapsing-Remitting Multiple SclerosisUnited States
-
Hoffmann-La RocheChugai PharmaceuticalCompletedNeuromyelitis Optica (NMO) | NMO Spectrum Disorder (NMOSD)United States, Korea, Republic of, Malaysia, Turkey, Bulgaria, Canada, Poland, Puerto Rico, Romania, Croatia, Georgia, Italy, Philippines, Taiwan, Ukraine
-
Shandong TheraWisdom Biopharma Co., Ltd.RecruitingAdvanced Melanoma | Advanced Urothelial CarcinomaChina
-
BiogenCompleted
-
Shandong TheraWisdom Biopharma Co., Ltd.Not yet recruiting
-
Hoffmann-La RocheRecruitingNeuromyelitis Optica Spectrum Disorder | NMOSDPoland, United Kingdom, Argentina, Italy, France, United States
-
BiogenActive, not recruitingMultiple SclerosisUnited States
-
Phoenix Neurological Associates, LTDUnknown
-
Amsterdam UMC, location VUmcErasmus Medical Center; St. Antonius Hospital; Rijnstate Hospital; OLVG; Prothya...CompletedMultiple SclerosisNetherlands
-
University of ChicagoBiogenCompletedMultiple SclerosisUnited States
-
University at BuffaloBiogenCompletedMultiple SclerosisUnited States
-
State University of New York at BuffaloCompletedMultiple SclerosisUnited States
-
BiogenTerminatedRelapsing-Remitting Multiple SclerosisUnited States, Spain, Germany, Australia, Sweden, Czechia, France, Italy, United Kingdom
-
BiogenCompleted
-
Alexion PharmaceuticalsTerminatedMultiple Myeloma | B-cell Chronic Lymphocytic LeukemiaUnited States
-
BiogenRecruiting
-
BiogenTerminated
-
BiogenCompletedEpilepsy, Focal Seizures, Partial SeizuresUnited States
-
Multiple Sclerosis Center of Northeastern New YorkActive, not recruitingMultiple SclerosisUnited States
-
BiogenCompletedMultiple Sclerosis, Relapsing-RemittingUnited States, Spain, Canada, Australia, Germany, Italy, United Kingdom, Belgium, Netherlands, France, Israel
-
Rigshospitalet, DenmarkUniversity of Copenhagen; Biogen; Copenhagen University Hospital, Hvidovre; Signifikans...CompletedPrimary Progressive Multiple Sclerosis | Secondary Progressive Multiple SclerosisDenmark
-
Kessler FoundationSt. Barnabas Medical CenterRecruitingMultiple Sclerosis, Relapsing-RemittingUnited States
-
International University of Health and WelfareJapan Agency for Medical Research and Development; Chugai Pharmaceutical; Keio...RecruitingPulmonary Arterial HypertensionJapan
-
BiogenAssociation for Functional Rehabilitation, Recreation and Applied Kinesiology...Recruiting
-
BiogenTerminatedMultiple Sclerosis, Relapsing-RemittingGermany
-
BiogenElan PharmaceuticalsCompletedMultiple Sclerosis, Relapsing-RemittingUnited Kingdom, United States, Canada, Belgium, Czech Republic, France, Germany, Netherlands
-
BiogenTerminatedRelapsing-Remitting Multiple SclerosisFinland, Germany, Spain, Belgium, Italy, Canada, France, New Zealand, Israel, Hungary, Greece, Australia, Netherlands, United Kingdom, Denmark, Ireland, Sweden, Poland, Czech Republic, Switzerland, Turkey
-
King's College LondonSouth London and Maudsley NHS Foundation TrustCompleted
-
University Hospital, ToulouseCompletedMultiple SclerosisFrance
-
BiogenElan PharmaceuticalsCompletedMultiple Sclerosis, Relapsing-Remitting
-
Alexion PharmaceuticalsQuintiles, Inc.Terminated
-
Case Comprehensive Cancer CenterRecruitingPulmonary Metastatic Osteosarcoma (pOS)United States
-
BiogenCompletedFatigue | Relapsing-Remitting Multiple SclerosisSweden, Norway, Austria, Denmark
-
Washington University School of MedicineBiogen; BioLineRx, Ltd.RecruitingSickle Cell DiseaseUnited States
-
BiogenCompletedRelapsing Remitting Multiple SclerosisPortugal
-
Genzyme, a Sanofi CompanyTerminatedRelapsing-remitting Multiple SclerosisRussian Federation, United States, Canada, Poland
-
SanofiTerminatedUlcerative ColitisUnited States
-
SanofiTerminatedUlcerative ColitisUnited States, Austria, Canada, France, Germany, Italy, Poland
-
Rennes University HospitalUnknownMultiple SclerosisFrance
-
BiogenCompletedRelapsing-Remitting Multiple SclerosisRussian Federation
-
BiogenCompletedRelapsing-Remitting Multiple SclerosisItaly
-
Hoffmann-La RocheChugai PharmaceuticalRecruitingMyelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD)Canada, United States, Korea, Republic of, Australia, Japan, Italy, Brazil, Germany, France, China, Israel
-
BiogenElan PharmaceuticalsCompletedSafety and Efficacy of Natalizumab in Combination With Avonex in the Treatment of Multiple SclerosisMultiple Sclerosis, Relapsing-RemittingUnited States, Germany, Austria, Belgium, France, Israel, Italy
-
Centre Hospitalier Universitaire de NiceRecruitingFacioscapulohumeral Muscular Dystrophy 1France, Canada
-
Hoffmann-La RocheChugai Pharmaceutical Co.RecruitingNMDAR Autoimmune Encephalitis | LGI1 Autoimmune EncephalitisUnited States, Korea, Republic of, China, Japan, Czechia, Italy, Poland, Austria, Brazil, Argentina, Netherlands, Taiwan, Denmark, France, Ghana
-
Queen Mary University of LondonBiogen; Barts & The London NHS Trust; Moorfields Eye Hospital NHS Foundation... and other collaboratorsRecruitingMultiple Sclerosis | Clinically Isolated Syndrome of DemyelinationUnited Kingdom
-
BiogenWithdrawn
-
John LevineBiogenCompletedAcute Graft Versus Host DiseaseUnited States